Drug resistant tuberculosis is beco

Drug resistant tuberculosis is becoming more common
Traditional laboratory methods for detecting drug resistance are slow and not generally available outside specialist laboratories. Rapid molecular methods are increasingly used in well resourced settings, and simple, cheap alternatives are being developed for resource limited settings
The evidence base to guide drug treatment of resistant tuberculosis is weak, and randomised controlled trials are needed
A service advising on the management of multidrug resistant tuberculosis is available in the United Kingdom
Priorities for prevention of drug resistant tuberculosis include prompt detection of cases, effective treatment of drug sensitive and drug resistant cases, and prevention of tuberculosis transmission